Personalized therapy with probiotics from the host by TripleA

Trends in Biotechnology

Volumn 32, Issue 6, 2014, Pages 291-293

  Kort, Remco ^a,b  

^a TNO   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; METRONIDAZOLE; PROBIOTIC AGENT; VANCOMYCIN;

BACTERIAL STRAIN; CLOSTRIDIUM DIFFICILE INFECTION; COLON FLORA; FECES MICROFLORA; HUMAN; INTESTINE FLORA; LACTOBACILLUS; LACTOBACILLUS CRISPATUS; LACTOBACILLUS GASSERI; LACTOBACILLUS INERS; LACTOBACILLUS JENSENII; LETTER; NONHUMAN; PERSONALIZED MEDICINE; PRIORITY JOURNAL; VAGINA FLORA; MICROFLORA; PROCEDURES;

HUMANS; INDIVIDUALIZED MEDICINE; MICROBIOTA; PROBIOTICS;

EID: 84901014030     PISSN: 01677799     EISSN: 18793096     Source Type: Journal    
DOI: 10.1016/j.tibtech.2014.04.002     Document Type: Letter

References (14)

1. Faith J.J., et al. The long-term stability of the human gut microbiota. Science 2013, 341:1237439.
2. Lee S.M., et al. Bacterial colonization factors control specificity and stability of the gut microbiota. Nature 2013, 501:426-429.
3. Structure, function and diversity of the healthy human microbiome. Nature 2012, 486:207-214. The human microbiome consortium.
4. Kurashima Y., et al. Mucosal innate immune cells regulate both gut homeostasis and intestinal inflammation. Eur. J. Immunol. 2013, 43:3108-3115.
5. Dols J.A., et al. Microarray-based identification of clinically relevant vaginal bacteria in relation to bacterial vaginosis. Am. J. Obstet. Gynecol. 2011, 204. 305.e1-7.
6. Ma B., et al. Vaginal microbiome: rethinking health and disease. Annu. Rev. Microbiol. 2012, 66:371-389.
7. Reid G. Modulating the vaginal microbiome: the need for a bridge between science and practice. Semin. Reprod. Med. 2014, 32:28-34.
8. Kort, R. TNO patent (2014) Production of personalized probiotics by in vitro enrichment of beneficial microorganisms from the host. European patent application No. 13181363.6.
9. Srinivasan S., et al. Bacterial communities in women with bacterial vaginosis: high resolution phylogenetic analyses reveal relationships of microbiota to clinical criteria. PLoS ONE 2012, 7:e37818.
10. Falagas M., et al. Probiotics for the treatment of women with bacterial vaginosis. Clin. Microbiol. Infect. 2007, 13:657-664.
11. Gough E., et al. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin. Infect. Dis. 2011, 53:994-1002.
12. Rajilic-Stojanovic M., et al. Evaluating the microbial diversity of an in vitro model of the human large intestine by phylogenetic microarray analysis. Microbiology 2010, 156:3270-3281.
13. Ladirat S.E., et al. High-throughput analysis of the impact of antibiotics on the human intestinal microbiota composition. J. Microbiol. Methods 2013, 92:387-397.
14. Venema K., van den Abbeele P. Experimental models of the gut microbiome. Best Pract. Res. Clin. Gastroenterol. 2013, 27:115-126.